Table 3 |
||||||
|
Risk prediction model for breast cancer with and without estradiol (loge) |
||||||
| No estradiol model |
||||||
|
|
||||||
| Parameter |
Beta |
SE |
P value |
Increment |
RR |
95% CI |
|
|
||||||
| Intercept |
-10.8 |
|||||
| Duration of premenopause, years |
0.102 |
0.009 |
<0.001 |
1 |
1.11 |
1.09, 1.13 |
| (Age at first birth minus age at menarche) × parousa |
0.0035 |
0.0051 |
0.49 |
10 |
1.04 |
0.94, 1.14 |
| Birth indexa |
-0.0030 |
0.0007 |
<0.001 |
102 |
0.74 |
0.64, 0.85 |
| Duration of postmenopause (natural menopause) |
0.049 |
0.006 |
<0.001 |
1 |
1.05 |
1.04, 1.06 |
| Duration of postmenopause (bilateral oophorectomy) |
0.039 |
0.008 |
<0.001 |
1 |
1.04 |
1.02, 1.06 |
| Benign breast disease |
0.288 |
0.656 |
0.66 |
1 |
1.33 |
0.37, 4.82 |
| Benign breast disease × age at menarche |
0.091 |
0.027 |
0.001 |
1 |
1.10 |
1.04, 1.15 |
| Benign breast disease × duration premenopause |
-0.018 |
0.012 |
0.14 |
1 |
0.98 |
0.96, 1.01 |
| Benign breast disease × duration postmenopause |
-0.029 |
0.008 |
<0.001 |
1 |
0.97 |
0.96, 0.99 |
| Duration of estrogen use |
0.032 |
0.008 |
<0.001 |
10 |
1.38 |
1.18, 1.61 |
| Duration of estrogen plus progestin use |
0.068 |
0.013 |
<0.001 |
10 |
1.97 |
1.53, 2.55 |
| Duration of other PMH use |
0.032 |
0.011 |
0.006 |
10 |
1.38 |
1.11, 1.71 |
| Current PMH use |
0.109 |
0.079 |
0.17 |
1 |
1.12 |
0.96, 1.30 |
| Past PMH use |
-0.022 |
0.073 |
0.76 |
1 |
0.98 |
0.85, 1.13 |
| Average BMI premenopause or postmenopause while on PMH × (duration premenopause +
duration postmenopause while on PMH) |
-0.0011 |
0.0003 |
<0.001 |
370b |
0.67 |
0.54, 0.83 |
| Average BMI postmenopause while not on PMH × (duration postmenopause while not on
PMH) |
0.0038 |
0.0006 |
<0.001 |
200c |
2.14 |
1.69, 2.71 |
| Height × (duration premenopause + duration postmenopause while on PMH) |
0.00072 |
0.00037 |
0.052 |
222d |
1.17 |
1.00, 1.38 |
| Height × (duration postmenopause while not on PMH) |
-1 × 10-5 |
0.0015 |
0.99 |
120e |
1.00 |
0.70, 1.42 |
| Cumulative alcohol consumption before menopause, grams |
0.00034 |
0.00009 |
<0.001 |
384f |
1.14 |
1.06, 1.22 |
| Cumulative alcohol consumption after menopause while on PMH |
-0.00036 |
0.00041 |
0.39 |
120g |
0.96 |
0.87, 1.05 |
| Cumulative alcohol consumption postmenopause while not on PMH |
0.00008 |
0.00031 |
0.80 |
240h |
1.02 |
0.88, 1.18 |
| Family history of breast cancer |
0.447 |
0.065 |
<0.001 |
1 |
1.56 |
1.38, 1.78 |
| Model including loge estradioli |
||||||
|
|
||||||
| Parameter |
Beta |
SE |
P value |
Increment |
RR |
95% CI |
|
|
||||||
| Intercept |
-11.9 |
|||||
| Duration of premenopause, years |
0.101 |
0.01 |
<0.001 |
1 |
1.11 |
1.08, 1.13 |
| (Age at first birth minus age at menarche) × parousa |
0.0035 |
0.0055 |
<0.001 |
10 |
1.04 |
0.93, 1.15 |
| Birth index |
-0.0020 |
0.0008 |
0.02 |
102 |
0.82 |
0.69, 0.96 |
| Duration of postmenopause (natural menopause) |
0.056 |
0.007 |
<0.001 |
1 |
1.06 |
1.04, 1.07 |
| Duration of postmenopause (bilateral oophorectomy) |
0.045 |
0.009 |
<0.001 |
1 |
1.05 |
1.03, 1.06 |
| Benign breast disease |
0.287 |
0.719 |
0.69 |
1 |
1.33 |
0.33, 5.45 |
| Benign breast disease × age at menarche |
0.091 |
0.029 |
0.002 |
1 |
1.10 |
1.03, 1.16 |
| Benign breast disease × duration premenopause |
-0.018 |
0.014 |
0.18 |
1 |
0.98 |
0.96, 1.01 |
| Benign breast disease × duration postmenopause |
-0.029 |
0.008 |
0.001 |
1 |
0.97 |
0.96, 0.99 |
| Duration of estrogen use |
0.032 |
0.009 |
<0.001 |
10 |
1.38 |
1.15, 1.64 |
| Duration of estrogen plus progestin use |
0.068 |
0.014 |
<0.001 |
10 |
1.97 |
1.50, 2.60 |
| Duration of other PMH use |
0.032 |
0.013 |
0.012 |
10 |
1.38 |
1.07, 1.78 |
| Current PMH use |
0.110 |
0.087 |
0.21 |
1 |
1.12 |
0.94, 1.32 |
| Past PMH use |
-0.022 |
0.080 |
0.78 |
1 |
0.98 |
0.84, 1.14 |
| Average BMI premenopause or postmenopause while on PMH × (duration premenopause +
duration postmenopause while on PMH) |
-0.0011 |
0.0003 |
<0.001 |
370b |
0.67 |
0.54, 0.83 |
| Average BMI postmenopause while not on PMH × (duration postmenopause while not on
PMH) |
0.0023 |
0.0007 |
0.002 |
200c |
1.58 |
1.20, 2.08 |
| Height × (duration premenopause + duration postmenopause while on PMH) |
0.00072 |
0.00041 |
0.072 |
222d |
1.17 |
0.98, 1.40 |
| Height × (duration postmenopause while not on PMH) |
0 |
0.0016 |
1 |
120e |
1.00 |
0.69, 1.46 |
| Cumulative alcohol consumption before menopause, grams |
0.00034 |
0.0001 |
0.001 |
384f |
1.14 |
1.06, 1.23 |
| Cumulative alcohol consumption after menopause while on PMH |
-0.00036 |
0.00045 |
0.43 |
120g |
0.96 |
0.86, 1.06 |
| Cumulative alcohol consumption postmenopause while not on PMH |
0.00008 |
0.00034 |
0.81 |
240h |
1.02 |
0.87, 1.20 |
| Family history of breast cancer |
0.446 |
0.072 |
<0.001 |
1 |
1.56 |
1.36, 1.80 |
| Loge estradiol |
0.477 |
0.092 |
<0.001 |
1 |
1.61 |
1.35, 1.93 |
|
|
||||||
|
a0 for nulliparous women. bComparing BMI = 20 versus BMI = 30 for 37 premenopausal years (age at menarche = 13, age at menopause = 50). cComparing BMI = 20 versus BMI = 30 for 20 postmenopausal years (age at menopause = 50, age = 70). dComparing height = 61 inches versus height = 67 inches for 37 premenopausal years (age at menarche = 13, age at menopause = 50). eComparing height = 61 inches versus height = 67 inches for 20 postmenopausal years (age at menopause = 50, age = 70). fComparing 1 drink per day (12 g) versus no intake for 32 premenopausal years (from age 18 to age 50). gComparing 1 drink per day (12 g) versus no intake for 10 years of PMH use. hComparing 1 drink per day (12 g) versus no intake for 20 postmenopausal years (age at menopause = 50, age = 70). iBased on an average of five imputations. BMI, body mass index; CI, confidence interval; PMH, postmenopausal hormone; RR, relative risk; SE, standard error. |
||||||
|
Rosner et al. Breast Cancer Research 2008 10:R55 doi:10.1186/bcr2110 |
||||||